LIVER CANCER RELATED GENES-SPECIFIC SIRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE SIRNA, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER COMPRISING THE SAME
The present invention relates to siRNA specific to gene related to liver cancer, and to a double-stranded oligo RNA structure including the same with high efficiency. The double-stranded oligo RNA structure includes a hydrophilic substance and a hydrophobic substance bound by simple covalent bonds o...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | YOON, PYOUNG OH KIM, HAN NA KIM, JAE EUN CHAE, JEI WOOK HAN, BO RAM PARK, JUN HONG JUNG, JUN SOO PARK, HAN OH KO, YOUNG HO YUN, SUNG IL CHOI, GI EUN |
| description | The present invention relates to siRNA specific to gene related to liver cancer, and to a double-stranded oligo RNA structure including the same with high efficiency. The double-stranded oligo RNA structure includes a hydrophilic substance and a hydrophobic substance bound by simple covalent bonds or linker-mediated covalent bonds on both ends thereof. Therefore, the double-stranded oligo RNA structure can be efficiently transported into a cell. The double-stranded oligo RNA structures can be transformed into nanoparticles by a hydrophobic interaction thereof in an aqueous solution. The siRNA included in the double-stranded oligo RNA structures is desirably specific to a gene related to liver cancer which particularly is Gankyrin or BMI-1. Moreover, the present invention relates to a method for producing the double-stranded oligo RNA structure, and to a pharmaceutical composition including the double-stranded oligo RNA structure for preventing or treating cancer, particularly liver cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20150006742A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20150006742A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20150006742A3</originalsourceid><addsrcrecordid>eNqNjrsOwjAMRbswIOAfLLFSqbznkLrFIo0rJ7AihMKEoFL5Mr6QUMHCxHTle44t95OnoQMKaGV1DEGjPOZQokWXuho1FaTBkVg1gZz3G4Op86JsHi02VDJEBBUb1HuDDjRXtZAjW4Lf4ncz-h1hR57YQsHS4VrwgLar3o2g8lWcgYvvR7_3VIXDpHc5Xdsw-uQgGRfo9TYNzf0Y2uZ0DrfwOO5klk2XWZat1ouZmv9nvQBkREpf</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LIVER CANCER RELATED GENES-SPECIFIC SIRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE SIRNA, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER COMPRISING THE SAME</title><source>esp@cenet</source><creator>YOON, PYOUNG OH ; KIM, HAN NA ; KIM, JAE EUN ; CHAE, JEI WOOK ; HAN, BO RAM ; PARK, JUN HONG ; JUNG, JUN SOO ; PARK, HAN OH ; KO, YOUNG HO ; YUN, SUNG IL ; CHOI, GI EUN</creator><creatorcontrib>YOON, PYOUNG OH ; KIM, HAN NA ; KIM, JAE EUN ; CHAE, JEI WOOK ; HAN, BO RAM ; PARK, JUN HONG ; JUNG, JUN SOO ; PARK, HAN OH ; KO, YOUNG HO ; YUN, SUNG IL ; CHOI, GI EUN</creatorcontrib><description>The present invention relates to siRNA specific to gene related to liver cancer, and to a double-stranded oligo RNA structure including the same with high efficiency. The double-stranded oligo RNA structure includes a hydrophilic substance and a hydrophobic substance bound by simple covalent bonds or linker-mediated covalent bonds on both ends thereof. Therefore, the double-stranded oligo RNA structure can be efficiently transported into a cell. The double-stranded oligo RNA structures can be transformed into nanoparticles by a hydrophobic interaction thereof in an aqueous solution. The siRNA included in the double-stranded oligo RNA structures is desirably specific to a gene related to liver cancer which particularly is Gankyrin or BMI-1. Moreover, the present invention relates to a method for producing the double-stranded oligo RNA structure, and to a pharmaceutical composition including the double-stranded oligo RNA structure for preventing or treating cancer, particularly liver cancer.</description><language>eng ; kor</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150119&DB=EPODOC&CC=KR&NR=20150006742A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150119&DB=EPODOC&CC=KR&NR=20150006742A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YOON, PYOUNG OH</creatorcontrib><creatorcontrib>KIM, HAN NA</creatorcontrib><creatorcontrib>KIM, JAE EUN</creatorcontrib><creatorcontrib>CHAE, JEI WOOK</creatorcontrib><creatorcontrib>HAN, BO RAM</creatorcontrib><creatorcontrib>PARK, JUN HONG</creatorcontrib><creatorcontrib>JUNG, JUN SOO</creatorcontrib><creatorcontrib>PARK, HAN OH</creatorcontrib><creatorcontrib>KO, YOUNG HO</creatorcontrib><creatorcontrib>YUN, SUNG IL</creatorcontrib><creatorcontrib>CHOI, GI EUN</creatorcontrib><title>LIVER CANCER RELATED GENES-SPECIFIC SIRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE SIRNA, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER COMPRISING THE SAME</title><description>The present invention relates to siRNA specific to gene related to liver cancer, and to a double-stranded oligo RNA structure including the same with high efficiency. The double-stranded oligo RNA structure includes a hydrophilic substance and a hydrophobic substance bound by simple covalent bonds or linker-mediated covalent bonds on both ends thereof. Therefore, the double-stranded oligo RNA structure can be efficiently transported into a cell. The double-stranded oligo RNA structures can be transformed into nanoparticles by a hydrophobic interaction thereof in an aqueous solution. The siRNA included in the double-stranded oligo RNA structures is desirably specific to a gene related to liver cancer which particularly is Gankyrin or BMI-1. Moreover, the present invention relates to a method for producing the double-stranded oligo RNA structure, and to a pharmaceutical composition including the double-stranded oligo RNA structure for preventing or treating cancer, particularly liver cancer.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjrsOwjAMRbswIOAfLLFSqbznkLrFIo0rJ7AihMKEoFL5Mr6QUMHCxHTle44t95OnoQMKaGV1DEGjPOZQokWXuho1FaTBkVg1gZz3G4Op86JsHi02VDJEBBUb1HuDDjRXtZAjW4Lf4ncz-h1hR57YQsHS4VrwgLar3o2g8lWcgYvvR7_3VIXDpHc5Xdsw-uQgGRfo9TYNzf0Y2uZ0DrfwOO5klk2XWZat1ouZmv9nvQBkREpf</recordid><startdate>20150119</startdate><enddate>20150119</enddate><creator>YOON, PYOUNG OH</creator><creator>KIM, HAN NA</creator><creator>KIM, JAE EUN</creator><creator>CHAE, JEI WOOK</creator><creator>HAN, BO RAM</creator><creator>PARK, JUN HONG</creator><creator>JUNG, JUN SOO</creator><creator>PARK, HAN OH</creator><creator>KO, YOUNG HO</creator><creator>YUN, SUNG IL</creator><creator>CHOI, GI EUN</creator><scope>EVB</scope></search><sort><creationdate>20150119</creationdate><title>LIVER CANCER RELATED GENES-SPECIFIC SIRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE SIRNA, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER COMPRISING THE SAME</title><author>YOON, PYOUNG OH ; KIM, HAN NA ; KIM, JAE EUN ; CHAE, JEI WOOK ; HAN, BO RAM ; PARK, JUN HONG ; JUNG, JUN SOO ; PARK, HAN OH ; KO, YOUNG HO ; YUN, SUNG IL ; CHOI, GI EUN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20150006742A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2015</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>YOON, PYOUNG OH</creatorcontrib><creatorcontrib>KIM, HAN NA</creatorcontrib><creatorcontrib>KIM, JAE EUN</creatorcontrib><creatorcontrib>CHAE, JEI WOOK</creatorcontrib><creatorcontrib>HAN, BO RAM</creatorcontrib><creatorcontrib>PARK, JUN HONG</creatorcontrib><creatorcontrib>JUNG, JUN SOO</creatorcontrib><creatorcontrib>PARK, HAN OH</creatorcontrib><creatorcontrib>KO, YOUNG HO</creatorcontrib><creatorcontrib>YUN, SUNG IL</creatorcontrib><creatorcontrib>CHOI, GI EUN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YOON, PYOUNG OH</au><au>KIM, HAN NA</au><au>KIM, JAE EUN</au><au>CHAE, JEI WOOK</au><au>HAN, BO RAM</au><au>PARK, JUN HONG</au><au>JUNG, JUN SOO</au><au>PARK, HAN OH</au><au>KO, YOUNG HO</au><au>YUN, SUNG IL</au><au>CHOI, GI EUN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LIVER CANCER RELATED GENES-SPECIFIC SIRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE SIRNA, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER COMPRISING THE SAME</title><date>2015-01-19</date><risdate>2015</risdate><abstract>The present invention relates to siRNA specific to gene related to liver cancer, and to a double-stranded oligo RNA structure including the same with high efficiency. The double-stranded oligo RNA structure includes a hydrophilic substance and a hydrophobic substance bound by simple covalent bonds or linker-mediated covalent bonds on both ends thereof. Therefore, the double-stranded oligo RNA structure can be efficiently transported into a cell. The double-stranded oligo RNA structures can be transformed into nanoparticles by a hydrophobic interaction thereof in an aqueous solution. The siRNA included in the double-stranded oligo RNA structures is desirably specific to a gene related to liver cancer which particularly is Gankyrin or BMI-1. Moreover, the present invention relates to a method for producing the double-stranded oligo RNA structure, and to a pharmaceutical composition including the double-stranded oligo RNA structure for preventing or treating cancer, particularly liver cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; kor |
| recordid | cdi_epo_espacenet_KR20150006742A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | LIVER CANCER RELATED GENES-SPECIFIC SIRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE SIRNA, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER COMPRISING THE SAME |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T13%3A01%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YOON,%20PYOUNG%20OH&rft.date=2015-01-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20150006742A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |